Polycystic Ovary Syndrome (PCOS) Clinical Trial
Official title:
The Role of DLBS3233 in the Management of Polycystic Ovary Syndrome (PCOS)
This is a 2-arm, randomized, double-blind, double-dummy, and controlled clinical study, with 6 months of treatment to evaluate the clinical and metabolic efficacy of DLBS3233 in improving reproductive parameters and to evaluate the safety of DLBS3233 in women with polycystic ovary syndrome compared with metformin, as an active control.
There will be 2 groups of treatment; each group will consist of 62 subjects with the
treatment regimens :
- Treatment I : 1 capsule of DLBS3233 100 mg (once daily) and 1 placebo caplet of
Metformin XR (twice daily)
- Treatment II : 1 caplet of Metformin XR 750 mg (twice daily) and 1 placebo capsule of
DLBS3233 (once daily) for 6 months of treatment.
Clinical examination to evaluate the efficacy of the investigational drug will be performed
at baseline and every interval of 1 month.
Laboratory examinations to evaluate the metabolic efficacy parameters and ultrasonography
(USG) examination will be performed at baseline, Month 3rd, and end of study (Month 6th). In
addition to that, USG will also be performed about 2 weeks after Month 3rd (Month 3.5th) and
after Month 5th (Month 5.5th).
Laboratory examinations to evaluate the reproductive efficacy parameters (reproductive
hormone levels) and safety, at baseline and Month 6th (end of study).
General counseling on lifestyle modification will be provided to the subjects by the assigned
Nutritionist. All study subjects should follow a lifestyle modification. Evaluation on
subjects' performance on lifestyle modification will be conducted every follow-up visit by
Investigator, but particularly at baseline, Month 3rd, and end of study (Month 6th) by the
Nutritionist.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT06306417 -
A Randomized Controlled Trial of Acupuncture for Insulin Resistance in Patients With Polycystic Ovary Syndrome
|
N/A | |
| Completed |
NCT01927471 -
Nutritional and Metabolic Correlates of Ovarian Morphology in Women With Polycystic Ovary Syndrome
|
||
| Completed |
NCT01927432 -
Ultrasound Characterization of Ovarian Follicle Dynamics in Women With Amenorrhea
|
||
| Completed |
NCT00805207 -
Sex Steroids, Sleep, and Metabolic Dysfunction in Women
|
N/A | |
| Completed |
NCT01999686 -
PCOS Treatment Using DLBS3233, Metformin, and Combination of Both
|
Phase 3 | |
| Completed |
NCT03414957 -
Malay Women With PCOS and Their Association With Metabolic Syndrome
|
||
| Recruiting |
NCT06143527 -
Safety of Cultured Allogeneic Adult Umbilical Cord Derived Mesenchymal Stem Cells for PCOS
|
Phase 1 | |
| Recruiting |
NCT05394142 -
A Clinical Trial to Evaluate the Efficacy, Tolerability, and Safety of a Fixed Dose Combination of Spironolactone, Pioglitazone & Metformin (SPIOMET) in Polycystic Ovary Syndrome (PCOS)
|
Phase 2 | |
| Completed |
NCT01233206 -
Metformin in High Responder Polycystic Ovary Syndrome (PCOS) Patients Undergoing IVF Cycles
|
Phase 4 | |
| Not yet recruiting |
NCT05272657 -
Low-Carb Versus Mediterranean Diet in PCOS
|
N/A | |
| Completed |
NCT04264832 -
Body Fat Distribution and Its Associated Factors in Chinese Women With Polycystic Ovary Syndrome
|
||
| Completed |
NCT03547453 -
Ovarian Ultrasonography for the Clinical Evaluation of Polycystic Ovary Syndrome
|
||
| Terminated |
NCT02865915 -
MLE4901 vs. Placebo for the Treatment of PCOS
|
Phase 2 | |
| Completed |
NCT02429128 -
14 Weeks Exercise Training on Lean Women With and Without PCOS
|
N/A | |
| Completed |
NCT01899001 -
Mood and Nutrition Interventions in Polycystic Ovary Syndrome
|
N/A | |
| Completed |
NCT03151005 -
The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS
|
Phase 4 | |
| Completed |
NCT03792282 -
Time-Restricted Feeding(TRF) on Overweight/Obese Women With Polycystic Ovarian Syndrome (PCOS)
|
N/A | |
| Completed |
NCT04852510 -
Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin
|
Phase 2/Phase 3 | |
| Recruiting |
NCT05200793 -
Efficacy of Empagliflozin or Linagliptin as an Alternative to Metformin for Treatment of Polycystic Ovary Syndrome
|
Phase 4 | |
| Not yet recruiting |
NCT01720459 -
Effects of Micronized Trans-resveratrol Treatment on Polycystic Ovary Syndrome (PCOS) Patients
|
N/A |